What is the Role of the Treatment Selection Working Group?
Meet the Chairs
Professor Tony Schapira
Professor Tony Schapira is head of the Department of Clinical and Movement Neurosciences at UCL Queen Square Institute of Neurology, and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery and the Royal Free London Hospital.
Professor Schapira’s research interests include the molecular, genetic and clinical aspects of Parkinson disease and the development of drugs for slowing its progress.
Professor Schapira co-leads our Treatment Selection Working Group with Professor Oliver Bandmann.
Professor Oliver Bandmann
Prof. Bandmann is Professor of Movement Disorders Neurology and Honorary Consultant Neurologist at the University of Sheffield.
Prof. Bandmann’s research focuses on movement disorders, with a particular interest in working towards disease-modifying therapy for Parkinson’s Disease to slow down progression.
Professor Bandmann co-leads our Treatment Selection Working Group which is tasked with developing a robust and transparent process by which to score and shortlist treatments with the greatest neuroprotective potential for entry into the EJS ACT-PD trial.
Members of this working group
|Edwin Jabbari, Early Career Researcher||University College London|
|Simon Stott||Cure Parkinson’s Trust, London|
|George Tofaris||University of Oxford|
|Esther Sammler||University of Dundee|
|Heather Mortiboys||University of Sheffield|
|Li Wei||University College London|
|Alan Wong||Royal Free London, NHS Foundation Trust|
|Susan Duty||Kings College London|
|David Dexter||Parkinson’s UK, London|
|Paula Scurfield||PPI member, Kent|
|Kevin McFarthing||PPI member, London|